Neutral
●
GlobeNewsWire
●
vor 5 Monaten
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa as chief technology officer (CTO), effective June 1, 2026. “Raj is a proven technology leader with the vision and execution experience to help scale our business and accelerate technology innovation...